healthcare

TSMC’s strong profits and planned expansion highlight AI’s impact on semiconductors, with the US investing heavily in Taiwan’s chip production. In retail, Amazon challenges Saks’ bankruptcy financing. Trump unveils a new healthcare plan focused on drug costs, diverging from ACA subsidy extensions. Goldman Sachs explores prediction markets, while NBCUniversal bets on a “Legendary February” of major sports events to boost viewership.

Major AI players like OpenAI, Google, and Anthropic have launched specialized medical AI tools, driven by competition. These platforms, like ChatGPT Health, MedGemma 1.5, and Claude for Healthcare, leverage multimodal LLMs fine-tuned on medical data to streamline administrative tasks such as prior authorization and claims processing. However, they are positioned as developer tools, not diagnostic products, and none currently have FDA clearance for clinical use. While benchmark performance shows improvements, real-world clinical validation and regulatory pathways remain significant hurdles. Current deployments focus on administrative workflows, not direct patient diagnosis or treatment decisions.

Zacks Small-Cap Research initiated coverage on Cosmos Health with a $4.50 price target. They highlight the company’s diversified, vertically integrated model, anticipating strong revenue growth driven by high-margin pharmaceuticals, nutraceuticals, telehealth, and AI R&D. The valuation is based on a five-year DCF analysis, factoring in U.S. market expansion, a $300 million financing facility, and digital asset strategy. Zacks also noted positive recent financial performance.

Amazon Pharmacy is expanding into the weight-loss drug market by offering Novo Nordisk’s oral Wegovy pill. This move increases patient access to the popular medication, previously dominated by injectables. Amazon aims to make treatment more accessible with pricing as low as $25 per month with insurance and $149 without. The integration with One Medical clinics further streamlines prescription fulfillment, highlighting Amazon’s growing presence in healthcare. This strategic expansion positions Amazon as a key player in reshaping weight management treatments.

A growing number of Britons are turning to AI for health information due to long GP wait times. Three in five use AI for symptom checking and understanding conditions, with younger demographics showing the highest engagement. AI offers speed, convenience, and comfort for many, though experts stress it’s not a replacement for professional medical advice. OpenAI’s ChatGPT Health aims to provide more personalized health insights by integrating with user data.

OpenAI launches ChatGPT Health, a specialized AI chatbot for personal health data. This tool connects users’ medical records and wellness apps, offering personalized insights without providing diagnoses or treatment. It operates in a secure, isolated environment, ensuring data privacy and preventing training of foundational models. The initiative partners with b.well for data connectivity and integrates with platforms like Apple Health and MyFitnessPal. Developed with medical professionals, ChatGPT Health aims to be a personal super-assistant for health and wellness queries.

Soren Acquisition Corp. has priced its initial public offering at $220 million, offering 22 million units at $10.00 each on Nasdaq under the ticker SORNU. The SPAC aims to merge with a company in the healthcare sector, leveraging experienced management. Each unit includes one Class A ordinary share and one-third of a redeemable warrant. BTIG, LLC is the sole book-running manager for the offering.

GE HealthCare (GEHC) declared a Q4 2025 cash dividend of $0.035 per share, payable February 13, 2026, to shareholders of record on January 9, 2026. This decision reflects the company’s commitment to shareholder value amidst increasing demand within the healthcare industry and technological advancements. GE HealthCare, a $19.7 billion global leader, focuses on medical technology, pharmaceutical diagnostics, and AI-enabled solutions. The company aims to optimize hospital efficiency and improve patient outcomes.

CarePlus is expanding its Medicare Advantage offerings in Florida for 2026, featuring up to 12 plan options across 20 counties. New additions include a Dual Eligible Special Needs Plan and a Chronic Condition Special Needs Plan targeting respiratory ailments. Select plans offer out-of-network specialist access and enhanced mental health benefits, plus integration with the Go365 wellness program. All plans have $0 premiums and $0 copays for primary care and select services. Enrollment is open October 15 – December 7.

AI is transforming healthcare by improving efficiency and alleviating burdens on professionals. While AI enhances diagnostics and drug discovery, a major focus is administrative streamlining through systems like Epic and startups like Abridge, reducing paperwork and documentation time. Venture capital strongly supports AI solutions for efficiency. However, a skills gap exists, prompting initiatives like Adtalem’s AI credentials program to equip clinicians. The goal is not replacement, but to empower clinicians to focus on patient care.